About Ori Biotech
Ori Biotech develops the IRO platform for cell and gene therapy manufacturing. This platform provides flexible tools for scientists to streamline development and automate processes. Ori Biotech aims to enable widespread patient access to cell and gene therapies.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
London, United Kingdom
Year Founded
2015
Team Size
11-50
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
oribiotech.com
Domain Registered Date
Aug 27, 2015
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $100,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Seed announced
- Milestone
X account created (@OriBiotech)
517 followers
- Milestone
Website domain registered
oribiotech.com
- Milestone
Company founded
London, United Kingdom
Investors & Backers
Amadeus Capital Partners
Chimera Investment
Delin Ventures
Kindred Capital
Northpond Ventures
Novalis LifeSciences
Octopus Ventures
Puhua Capital
Funding History
Series-B+
· Jan 18, 2022
$100,000,000 fundraisingfox.com
Seed
· Jan 9, 2020
Undisclosed Source
Founders & Leadership
Chris Mason
Founder
Work email & phone locked
Unlock →
Farlan Veraitch
Founder
Work email & phone locked
Unlock →
Jason Bock
Co-Founder and CEO
Work email & phone locked
Unlock →
Jason Foster
Chief Executive Officer and Executive Director
Work email & phone locked
Unlock →
Thomas Heathman
Vice President of Commercial Operations
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026